UFP Technologies, Inc. (UFPT)
NASDAQ: UFPT · Real-Time Price · USD
219.44
+4.57 (2.13%)
At close: Dec 12, 2025, 4:00 PM EST
218.78
-0.66 (-0.30%)
After-hours: Dec 12, 2025, 4:38 PM EST
UFP Technologies Revenue
UFP Technologies had revenue of $154.56M in the quarter ending September 30, 2025, with 6.47% growth. This brings the company's revenue in the last twelve months to $597.95M, up 29.47% year-over-year. In the year 2024, UFP Technologies had annual revenue of $504.42M with 26.08% growth.
Revenue (ttm)
$597.95M
Revenue Growth
+29.47%
P/S Ratio
2.82
Revenue / Employee
$144,224
Employees
4,146
Market Cap
1.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 504.42M | 104.35M | 26.08% |
| Dec 31, 2023 | 400.07M | 46.28M | 13.08% |
| Dec 31, 2022 | 353.79M | 147.47M | 71.48% |
| Dec 31, 2021 | 206.32M | 26.95M | 15.02% |
| Dec 31, 2020 | 179.37M | -19.01M | -9.58% |
| Dec 31, 2019 | 198.38M | 7.93M | 4.16% |
| Dec 31, 2018 | 190.46M | 42.61M | 28.82% |
| Dec 31, 2017 | 147.84M | 1.71M | 1.17% |
| Dec 31, 2016 | 146.13M | 7.28M | 5.24% |
| Dec 31, 2015 | 138.85M | -457.00K | -0.33% |
| Dec 31, 2014 | 139.31M | 84.00K | 0.06% |
| Dec 31, 2013 | 139.22M | 8.26M | 6.31% |
| Dec 31, 2012 | 130.96M | 3.72M | 2.92% |
| Dec 31, 2011 | 127.24M | 6.48M | 5.36% |
| Dec 31, 2010 | 120.77M | 21.54M | 21.70% |
| Dec 31, 2009 | 99.23M | -10.80M | -9.82% |
| Dec 31, 2008 | 110.03M | 16.44M | 17.56% |
| Dec 31, 2007 | 93.60M | -154.10K | -0.16% |
| Dec 31, 2006 | 93.75M | 9.79M | 11.66% |
| Dec 31, 2005 | 83.96M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
UFPT News
- 12 days ago - UFP Technologies Announces CEO Succession Plan - GlobeNewsWire
- 19 days ago - UFP Technologies to Present and Host 1X1 Investor Meetings at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - UFP Technologies, Inc. (UFPT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - UFP Technologies Announces Strong Q3 2025 Results - GlobeNewsWire
- 6 weeks ago - UFP Technologies to Report Third Quarter 2025 Financial Results on November 3, 2025 - GlobeNewsWire
- 3 months ago - UFP Industries: A Strong Contender in a Fragmented Lumber Market - The Motley Fool
- 4 months ago - UFP Technologies to Present and Host 1x1 Investor Meetings at the 16th Annual Midwest IDEAS Investor Conference on August 26th in Chicago, IL - GlobeNewsWire
- 4 months ago - UFP Technologies: A Comforting Quarter - Seeking Alpha